Transcutaneous bilirubin measurement in preterm infants less than 35 weeks of gestation
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261894Keywords:
Hyperbilirubinemia, Neonatal intensive care unit, Preterm infants, Serum bilirubin, Transcutaneous bilirubinAbstract
Background: Neonatal hyperbilirubinemia is a common clinical condition in preterm infants due to hepatic immaturity and increased bilirubin production. Monitoring bilirubin levels is essential to prevent bilirubin-induced neurological dysfunction. Total serum bilirubin (TSB) estimation is considered the gold standard for diagnosis and monitoring; however, repeated blood sampling in preterm infants may lead to iatrogenic blood loss, procedural pain and increased risk of infection. Transcutaneous bilirubin (TcB) measurement offers a rapid, non-invasive alternative for bilirubin estimation, but its reliability in very preterm infants requires further evaluation.
Methods: A hospital-based cross-sectional study was conducted over twelve months (June 2024-July 2025) in the neonatal intensive care unit in RajaRajeswari Medical College and Hospital. Preterm infants born before 35 weeks of gestation fulfilling inclusion criteria were enrolled. Transcutaneous bilirubin measurements were obtained using a TcB device from the forehead or sternum. Blood samples for serum bilirubin estimation were collected simultaneously or shortly after TcB measurement. Data were analysed using SPSS version 23. Pearson correlation coefficient and Bland–Altman analysis was used to assess correlation and agreement between TcB and TSB values.
Results: Sixty-three paired TcB and TSB measurements were analysed. The mean TcB value was 8.20±1.70 mg/dl, while the mean TSB value was 8.75±1.80 mg/dl. A strong positive correlation was observed between TcB and TSB (r=0.864, p<0.001). Bland–Altman analysis showed a mean difference of 0.546 mg/dl with acceptable limits of agreement.
Conclusions: Transcutaneous bilirubin measurement demonstrates strong correlation and good agreement with serum bilirubin levels in preterm infants less than 35 weeks of gestation. TcB is a reliable non-invasive tool for monitoring neonatal jaundice and may reduce the need for frequent blood sampling in neonatal intensive care units.
References
Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med. 2017;78:699-704.
Counsilman CE, Heeger LE, Tan R, Bekker V, Zwaginga JJ, Te Pas AB. Iatrogenic blood loss in extreme preterm infants due to frequent laboratory tests and procedures. J Matern Fetal Neonatal Med. 2021;34:2660-5.
Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population ≥35 weeks’ gestation. Pediatrics. 2006;117:1169-73.
Engle WD, Jackson GL, Engle NG. Transcutaneous bilirubinometry. Semin Perinatol. 2014;38:438-51.
Nagar G, Vandermeer B, Campbell S, Kumar M. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics. 2013;132:871-81.
Schmidt ET, Wheeler CA, Jackson GL, Engle WD. Evaluation of transcutaneous bilirubinometry in preterm neonates. J Perinatol. 2009;29:564-9.
Chawla D, Jain S, Kaur G, Sinhmar V, Guglani V. Accuracy of transcutaneous bilirubin measurement in preterm low-birth-weight neonates. Eur J Pediatr. 2014;173:173-9.
Counsilman CE, Heeger LE, Tan R, Bekker V, Zwaginga JJ, Te Pas AB. Iatrogenic blood loss in extreme preterm infants. J Matern Fetal Neonat Med. 2021;34:2660-5.
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia. Pediatrics. 1999;103:6-14.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant ≥35 weeks. Pediatrics. 2004;114:297-316.
De Luca D, Zecca E, Romagnoli C. Skin bilirubin measurement during phototherapy in preterm infants. Early Hum Dev. 2007;83:165-8.
Romagnoli C, Zecca E, Catenazzi P, Barone G, Fanos V. Transcutaneous bilirubin measurement: comparison with total serum bilirubin in preterm and term newborns. Acta Paediatr. 2000;89:146-51.
Taylor JA, Burgos AE, Flaherman V. Discrepancies between transcutaneous and serum bilirubin measurements. Pediatrics. 2015;135:224-31.
Bhatt DR, Kristensen-Cabrera AI, Lee HC. Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California neonatal intensive care units. J Perinatol. 2018;38:1532–5.
Chawla D, Jain S, Kaur G. Accuracy of transcutaneous bilirubin measurement in preterm low-birth-weight neonates. European J Pediatrics. 2016;73:173–9.
Downloads
Published
How to Cite
Issue
Section
